Document Detail


Assessment of myocardial ischemia with cardiovascular magnetic resonance.
MedLine Citation:
PMID:  22014487     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Assessment of myocardial ischemia in symptomatic patients remains a common and challenging clinical situation faced by physicians. Risk stratification by presence of ischemia provides important utility for both prognostic assessment and management. Unfortunately, current noninvasive modalities possess numerous limitations and have limited prognostic capacity. More recently, ischemia assessment by cardiovascular magnetic resonance (CMR) has been shown to be a safe, available, and potentially cost-effective alternative with both high diagnostic and prognostic accuracy. Cardiovascular magnetic resonance has numerous advantages over other noninvasive methods, including high temporal and spatial resolution, relatively few contraindications, and absence of ionizing radiation. Furthermore, studies assessing the clinical utility and cost effectiveness of CMR in the short-term setting for patients without evidence of an acute myocardial infarction have also demonstrated favorable results. This review will cover techniques of ischemia assessment with CMR by both stress-induced wall motion abnormalities as well as myocardial perfusion imaging. The diagnostic and prognostic performance studies will also be reviewed, and the use of CMR for ischemia assessment will be compared with other commonly used noninvasive modalities.
Authors:
Bobak Heydari; Michael Jerosch-Herold; Raymond Y Kwong
Related Documents :
12898827 - The behaviours of the inhabitants of the lublin region in the situations of sudden card...
20347207 - Glucagon-like peptide-1 (glp-1) attenuates post-resuscitation myocardial microcirculato...
6151817 - Considerations in the long-term management of survivors of cardiac arrest.
15889197 - Aminophylline: exploring cardiovascular benefits versus medical malcontent.
11074217 - Effect of heterozygosity for the methionine synthase 2756 a-->g mutation on the risk fo...
6117297 - Prognostic significance of electrocardiographic findings in angina at rest. therapeutic...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Progress in cardiovascular diseases     Volume:  54     ISSN:  1873-1740     ISO Abbreviation:  Prog Cardiovasc Dis     Publication Date:    2011 Nov-Dec
Date Detail:
Created Date:  2011-10-21     Completed Date:  2011-12-06     Revised Date:  2014-04-02    
Medline Journal Info:
Nlm Unique ID:  0376442     Medline TA:  Prog Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  191-203     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011. Published by Elsevier Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiotonic Agents / diagnostic use
Coronary Circulation
Humans
Magnetic Resonance Imaging*
Myocardial Ischemia / diagnosis*,  physiopathology
Myocardial Perfusion Imaging / methods*
Predictive Value of Tests
Prognosis
Severity of Illness Index
Vasodilator Agents / therapeutic use
Grant Support
ID/Acronym/Agency:
R01 HL091157/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Vasodilator Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular magnetic resonance: physics and terminology.
Next Document:  Evaluation of myocardial viability with cardiac magnetic resonance imaging.